GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals Ltd shares are currently trading at Rs 2,421 which is at an increase of 20 percent.

ICICI Securities raised its estimates on GSK Pharma for the company’s FY25–26E earnings per share, to approximately 5 to 6 percent. This was mainly due to better margin outlook. Therefore, it upgraded its rating of the shares to ‘Add’ with lower target price of Rs 2,250 based on 38x FY26 estimates of earnings per share.

Meanwhile, Motilal Oswal also increased its earnings estimates for the company by 2 percent/5 percent/7 percent for FY25/FY26/FY27 to factor in a) differentiated launches in cancer therapy, b) scale-up of vaccine business, c) enhanced efforts to boost vaccine prospects. The brokerage valued GSK Pharma at a target price of Rs 2,170.

For the quarter ended December, of the current fiscal year 2025, the company’s revenue from operations grew by 17.9 percent YoY to Rs 9.5 billion while its gross margin (GM) contracted by 150bp YoY, to reach 62.2 percent. The decline was a result of a change in the product mix.

Related Posts

  • Pharma
  • July 3, 2025
  • 57 views
Cipla in talks to add new customers for its China factory, executive says

SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to…

  • Pharma
  • July 3, 2025
  • 43 views
No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cipla in talks to add new customers for its China factory, executive says

Cipla in talks to add new customers for its China factory, executive says

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs